Estrella Immunopharma, Inc.

ESLA · XNAS

CIK 1844417fmd_1PMRP0C8J1SYXEHQAK694VHCYYManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 06, 2021 to Jun 30, 2026, 22 periods

Ratios computed from the standardized statements. Select a value to open its proof.